Hypoglycemia (low blood sugar) - this is more likely in people taking other medications for diabetes management
With the increasing use of long-acting GLP-1 receptor agonists like semaglutide and tirzepatide, its important to understand how chronic high-dose exposure may lead to receptor desensitization and downregulation potentially impacting long-term efficacy
For the current study, Ranganath and colleagues reviewed records for all patients treated for RA at UCLA from 2018 to 2024, focusing on those with body mass index (BMI) values of at least 27 who received prescriptions for either semaglutide (Wegovy, Ozempic, Rybelsus) or tirzepatide (Mounjaro, Zepbound)
This includes 2,700% year-over-year growth in NAD+ patches, a 1,700% spike in GLP-1 patches, 307% growth for collagen eye patches and a 101% increase in sleep patches in 2025, according to Spate
Example 1: Primary care practice with Semaglutide offering for patients